JJJuracy Bertoldo Junior

Juracy Bertoldo Junior

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juracy Bertoldo Junior has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing the Generalizability of a Phonetic Text Clustering Method for Mining Clinical Data from the Electronic Health Records of Patients with Post-COVID-19 Syndrome (Preprint)

    by Pilar Tavares Veras Florentino, Vinicius de Araújo Oliveira, Francisco Jerônimo da Silva Júnior, Valéria Paes Lima, Eduardo Padilha Antonio, Izabel Marcilio, Henrique Gomides Zatti, George Caique Gouveia Barbosa, Juracy Bertoldo Santos Junior, Renata David Bernades, et al.

  • Open Access

    Primary health care data-based early warning system for dengue outbreaks: a nationwide case study in Brazil

    by Rejane Santos-Silva, Pilar Tavares Veras Florentino, Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Juracy Bertoldo Junior, George C.G. Barbosa, Gerson O. Penna, Viviane S. Boaventura, Pablo I. Pereira Ramos, Manoel Barral-Netto, et al.


  • Open Access

    Impact of Primary Health Care Data Quality on Infectious Disease Surveillance in Brazil: Case Study

    by Pilar Tavares Veras Florentino, Juracy Bertoldo Junior, George Caique Gouveia Barbosa, Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Marcio Henrique de Oliveira Garcia, Gerson Oliveira Penna, Viviane Boaventura, Pablo Ivan Pereira Ramos, Manoel Barral-Netto, et al.

    Background: The increase in emerging and re-emerging infectious disease outbreaks underscores the need for robust early warning systems (EWSs) to guide mitigation and response measures. Administrative health care databases provide valuable epidemiological insights without imposing additional burdens on health services. However, these datasets are primarily collected for operational use, making data quality assessment essential to ensure an accurate interpretation of epidemiological analysis. This study focuses on the development and implementation of a data quality index (DQI) for surveillance integrated into an EWS for influenza-like illness (ILI) outbreaks using Brazil’s a nationwide Primary Health Care (PHC) dataset. Objective: We aimed to evaluate the impact of data completeness and timeliness on the performance of an EWS for ILI outbreaks and establish optimal thresholds for a suitable DQI, thereby improving the accuracy of outbreak detection and supporting public health surveillance. Methods: A composite DQI was established to measure the completeness and timeliness of PHC data from the Brazilian National Information System on Primary Health Care. Completeness was defined as the proportion of weeks within an 8-week rolling window with any register of encounters. Timeliness was calculated as the interval between the date of encounter and its corresponding registry in the information system. The backfilled PHC dataset served as the gold standard to evaluate the impact of varying data quality levels from the weekly updated real-time PHC dataset on the EWS for ILI outbreaks across 5570 Brazilian municipalities from October 10, 2023, to March 10, 2024. Results: During the study period, the backfilled dataset recorded 198,335,762 ILI-related encounters, averaging 8,623,294 encounters per week. The EWS detected a median of 4 (IQR 2‐5) ILI outbreak warnings per municipality using the backfilled dataset. Using the real-time dataset, 12,538 (65%) warnings were concordant with the backfilled dataset. Our analysis revealed that 100% completeness yielded 76.7% concordant warnings, while 80% timeliness resulted in at least 50% concordant warnings. These thresholds were considered optimal for a suitable DQI. Restricting the analysis to municipalities with a suitable DQI increased concordant warnings to 80.4%. A median of 71% (IQR 54%-71.9%) of municipalities met the suitable DQI threshold weekly. Municipalities with ≥60% of weeks achieving a suitable DQI demonstrated the highest concordance between backfilled and real-time datasets, with those achieving ≥80% of weeks showing 82.3% concordance. Conclusions: Our findings highlight the critical role of data quality in improving the EWS’ performance based on PHC data for detecting ILI outbreaks. The proposed framework for real-time DQI monitoring is a practical approach and can be adapted to other surveillance systems, providing insights for similar implementations. We demonstrate that optimal completeness and timeliness of data significantly impact the EWS’ ability to detect ILI outbreaks. Continuous monitoring and improvement of data quality should remain a priority to strengthen the reliability and effectiveness of surveillance systems.


  • Open Access

    Leveraging the power of digital health to fight pandemics: The example of ÆSOP

    by Izabel Marcilio, Pilar Veras Tavares Florentino, Thiago Cerqueira-Silva, Juracy Bertoldo-Junior, George Caique Gouveia Barbosa, Vinícius de Araujo Oliveira, Viviane Boaventura, Gerson Oliveira Penna, Pablo Ivan Pereira Ramos, Manoel Barral-Netto

    Emerging outbreaks highlight the need for early warning systems, but low-resource centers often face challenges to maintain surveillance capabilities. Administrative data-based systems offer a cost-efficient approach to strengthening surveillance. The present study evaluated whether a primary health care (PHC)-based early warning system could anticipate respiratory outbreak detection, when compared to traditional surveillance. Weekly counts of influenza-like illness PHC encounters in Rio de Janeiro were analyzed from October 2019 to May 2020 and from October 2021 to May 2022. PHC data was compared to weekly surveillance notifications and used time series regression to estimate predicted counts of PHC encounters. Subsequent outbreak warnings were then issued. Our study identified 659,230 influenza-like illness PHC encounters in the first period, and 702,886 in the second period. In the first period, PHC data deviated from baseline two weeks before the rise in notifications during the first COVID-19 wave and one week earlier in the second period. The PHC-based system successfully triggered warnings capable of anticipating the surveillance system. Our findings show PHC-based early warning systems can anticipate outbreaks earlier than traditional surveillance, supporting their role in enhancing surveillance in low-resource settings.

  • Open Access

    The geographical access of users with diabetes and hypertension to the 'there's a people's pharmacy here' programme (atfp), brazil

    by Marcio Natividade, Kionna Bernardes Santos, Juracy Bertoldo, Vinícius Mendes, Daniela Morato, Samilly Miranda1, Luís Eugênio Portela, Erika Aragão

    Introduction: Access to medication constitutes one of the most important socio-economic challenges to treatment continuity. In Brazil, one initiative to expand access to the medication available through primary healthcare is the ‘There’s a People’s Pharmacy Here’ Programme _(Programa...

  • Open Access

    Effect of the 'there's a people's pharmacy here' programme on hypertension and diabetes-related mortality

    by Samilly Miranda, Kionna Oliveira Bernardes Santos, Marcio Natividade, Juracy Bertoldo, Vinícius de Araújo Mendes, Luís Eugenio Portela Fernandes de Souza, Erika Santos de Aragão

    Background and objective: Information about the real prevalence of non-communicable diseases (NCDs) in Brazil, and their rate of treatment and control, remains scarce. Despite the evolution of technologies for medical treatment, some sections of the population do not adhere to it. This study...

  • Open Access

    Effectiveness of the CoronaVac Vaccine in Prevention of Symptomatic and Progression to Severe COVID-19 in Pregnant Women in Brazil

    by Enny S. Paixão, Kerry Lm Wong, Flávia Jôse O. Alves, Vinicius de Araújo Oliveira, Thiago Cerqueira-Silva, Juracy Bertoldo Júnior, Tales Mota Machado, Elzo Pereira Pinto Júnior, Viviane Boaventura, Gerson O. Penna, et al.

    Background: The effectiveness of Covid-19 inactivated vaccines in pregnant women is unknown. We estimated vaccine effectiveness (VE) of CoronaVac against symptomatic and severe Covid-19 and in preventing progression from symptomatic to severe Covid-19 in pregnant women in Brazil. Methods: We conducted a test-negative design study in all pregnant women aged 18 to 49 years in Brazil, linking records of negative and positive SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) tests to national vaccination records. We also linked records of test positive cases with notification of severe, hospitalized or fatal Covid-19. Using logistic regression, we estimated adjusted odds and VE against symptomatic Covid-19 by comparing vaccine status in test positive (confirmed cases) to that in subjects with a negative test result. We also calculated the odds/VE against progression by comparing vaccine status in symptomatic cases to that in severe Covid-19 cases. Results: Of 19838 tested pregnant women, 7424 (37.4%) tested positive for Covid-19 and 588 (7.9%) had severe disease. Only 83% of pregnant women who received a first dose of CoronaVac completed the vaccination scheme. A single dose of the CoronaVac vaccine was not effective at preventing symptomatic Covid-19. Effectiveness of two doses of CoronaVac was 41% (95% CI 27.1- 52.2) against symptomatic Covid-19, 85% (95% CI 59.5-94.8) against severe Covid-19 and (75%; 95% CI 27.9- 91.2) in preventing progression to severe Covid-19 among those infected. Conclusion: A complete regimen of CoronaVac in pregnant women was effective in preventing symptomatic Covid-19, and highly effective against severe illness in a setting that combines high disease burden and elevated Covid-19 related maternal deaths. Funding Information: This study is part of the VigiVac Fiocruz program, partially supported by a donation from the "Fazer o bem faz bem" program. EPS is funded by the Wellcome Trust [Grant number 213589/Z/18/Z]. Declaration of Interests: We declare no competing interests. VO, VB, MB, and MB-N are employees from Fiocruz, a federal public institution, which manufactures Vaxzevria in Brazil, through a full technology transfer agreement with AstraZeneca Ethics Approval Statement: This study analysed de-identified data and was approved by the National Ethics committee (CONEP) (CAAE registration no. 50199321.9.0000.0040).


  • Open Access

    Distanciamento social e condições de vida na pandemia COVID-19 em Salvador-Bahia, Brasil

    by Marcio dos Santos Natividade, Kionna Bernardes, Marcos Pereira, Samilly Silva Miranda, Juracy Bertoldo, Maria da Glória Teixeira, Humberto Lago Livramento, Erika Aragão

    Resumo Na pandemia COVID-19, estados e municípios brasileiros adotaram medidas de distanciamento social como estratégia para reduzir o número de casos e o controle da doença. Estas medidas atingem de forma diferenciada estratos populacionais e território. O objetivo deste estudo foi analisar a evolução do distanciamento social adotadas para o controle da pandemia COVID-19 e sua relação com as condições de vida da população do município de Salvador, Bahia. Foi conduzido um estudo ecológico utilizando agregados espaciais. Calculou-se o Índice de Isolamento Social do município e o Índice de Condição de Vida. O Índice de Moran Global e Local foram usados para avaliar o grau de dependência e autocorrelação espacial. Observou-se oscilações nos índices de isolamento social durante o período analisado, com maiores percentuais de isolamento nos bairros com condições de vida mais favoráveis. A análise e a interpretação das medidas de contenção da Covid-19, a exemplo do distanciamento social, deve considerar o perfil de vulnerabilidade de cada território visando a monitorar o correto dimensionamento das estratégias de mitigação da pandemia, na perspectiva de desenvolver ações sociais capazes de possibilitar maior adesão das populações mais desfavorecidas.